We are live on
!
Find out more
Sanders Capital Portfolio holdings
AUM
$83.9B
1-Year Est. Return
37.89%
This Fund
S&P 500
This Quarter
Est. Return
+10.13%
1 Year Est. Return
+37.89%
3 Year Est. Return
+120.64%
5 Year Est. Return
+154.21%
10 Year Est. Return
+678.77%
AUM
$18.4B
AUM Growth
+$1.8B
(+11%)
Cap. Flow
+$281M
Cap. Flow
% of AUM
1.53%
Top 10 Holdings %
Top 10 Hldgs %
55.38%
Holding
42
New
4
Increased
24
Reduced
13
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$382M |
| 2 |
Kroger
KR
|
+$227M |
| 3 |
Halliburton
HAL
|
+$137M |
| 4 |
Pfizer
PFE
|
+$92.7M |
| 5 |
Johnson & Johnson
JNJ
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$357M |
| 2 |
Range Resources
RRC
|
+$303M |
| 3 |
Meritage Homes
MTH
|
+$81.5M |
| 4 |
D.R. Horton
DHI
|
+$68.5M |
| 5 |
Lennar Class A
LEN
|
+$34.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.01% |
| 2 | Technology | 24.96% |
| 3 | Financials | 16.5% |
| 4 | Consumer Discretionary | 9% |
| 5 | Communication Services | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Merck
MRK
$318B
| $202M | 1.1% |
3,758,396
-6,434,920
| -63% | -$357M |
|
27
Omnicom Group
OMC
$23.4B
| $187M | 1.02% |
2,571,342
-7,100
| -0.3% | -$509K |
|
28
BP
BP
$107B
| $165M | 0.9% |
4,278,826
-64,340
| -1% | -$2.33M |
|
|
29
Halliburton
HAL
$26.6B
| $152M | 0.83% |
+3,112,650
| New | +$137M |
|
30
Stanley Black & Decker
SWK
$15.7B
| $139M | 0.76% |
820,248
-2,400
| -0.3% | -$393K |
|
31
Synchrony
SYF
$25.6B
| $108M | 0.59% |
2,795,440
+45,400
| +2% | +$1.55M |
|
|
32
Meritage Homes
MTH
$4.86B
| $78.5M | 0.43% |
3,066,958
-3,290,200
| -52% | -$81.5M |
|
33
Aptiv
APTV
$10.3B
| $75.6M | 0.41% |
891,421
-2,300
| -0.3% | -$219K |
|
34
AbbVie
ABBV
$435B
| $60.6M | 0.33% |
626,133
-1,400
| -0.2% | -$132K |
|
35
Genuine Parts
GPC
$18.7B
| $59.8M | 0.33% |
629,377
-2,100
| -0.3% | -$192K |
|
36
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
| $27.1M | 0.15% |
496,136
+15,000
| +3% | +$807K |
|
|
DLPH
37
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $15.6M | 0.08% |
+297,138
| New | +$15.4M |
|
38
Shinhan Financial Group
SHG
$35.6B
| $10.5M | 0.06% |
225,794
+12,100
| +6% | +$543K |
|
39
Barclays
BCS
$94.1B
| $5.91M | 0.03% |
566,977
+25,731
| +5% | +$250K |
|
40
Honda
HMC
$41.3B
| $5.43M | 0.03% |
159,381
-3,100
| -2% | -$100K |
|
|
41
Lennar Class B
LEN.B
$20.8B
| $5.16M | 0.03% |
+105,019
| New | +$4.85M |
|
|
42
Range Resources
RRC
$8.95B
| – | – |
-15,485,365
| Closed | -$303M |
|
Similar funds
Sanders Capital's Q4 2017 Portfolio in Review
As of Q4 2017, Sanders Capital held 42 positions worth $18.4B, up 11% from $16.6B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Sanders Capital's Q4 2017 filing shows 4 new, 24 increased, 13 reduced and 1 closed positions. Its largest new stake was Kroger: 9,739,142 shares worth $267M. The largest sale was Merck, an estimated $357M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Sanders Capital's largest Q4 2017 buy was Kroger: 9,739,142 shares worth $267M.
- Sanders Capital added most to Gilead Sciences in Q4 2017, an estimated $382M increase.
- Sanders Capital's biggest Q4 2017 reduction was Merck, cutting an estimated $357M.
- Sanders Capital fully exited Range Resources in Q4 2017, selling an estimated $303M.
- Sanders Capital's ten largest holdings make up 55% of its $18.4B portfolio in Q4 2017.
- Sanders Capital opened 4 new positions and closed 1 in Q4 2017.
- Sanders Capital's portfolio value rose 11% quarter-over-quarter to $18.4B.
Based on Sanders Capital's 13F filing for Q4 2017, filed 31 Jan 2018.